| EIMGX | VISGX | EIMGX / VISGX | |
| Total Expense Ratio | 0.88 | 0.19 | 463% |
| Annual Report Gross Expense Ratio | 0.88 | 0.19 | 463% |
| Fund Existence | 16 years | 28 years | - |
| Gain YTD | -6.433 | 7.920 | -81% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000000 | 3000 | 33,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 117M | 39.7B | 0% |
| Annual Yield % from dividends | 0.40 | 0.43 | 91% |
| Returns for 1 year | -13.83 | 3.97 | -348% |
| Returns for 3 years | 5.96 | 41.11 | 14% |
| Returns for 5 years | 11.58 | 27.42 | 42% |
| Returns for 10 years | 29.93 | 154.40 | 19% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| JFNIX | 81.53 | 0.73 | +0.90% |
| Janus Henderson Global Life Sciences I | |||
| IINCX | 25.73 | 0.16 | +0.63% |
| Macquarie International Core Eq R6 | |||
| PCSVX | 17.44 | 0.05 | +0.29% |
| PACE Small/Medium Co Value Equity P | |||
| SAGAX | 60.41 | -0.18 | -0.30% |
| Virtus Zevenbergen Innovative Gr Stk A | |||
| ICPAX | 7.12 | -0.06 | -0.84% |
| Integrity Mid-North American Resources A | |||